Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

584 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combi-TED: a new trial testing Tedopi® with docetaxel or nivolumab in metastatic non-small-cell lung cancer progressing after first line.
Landi L, Delmonte A, Bonetti A, Pasello G, Metro G, Mazzoni F, Borra G, Giannarelli D, Andrikou K, Mangiola D, Gori S, D'Andrea MR, Minuti G, Resuli B, Laudisi A, Vidiri A, Conti L, Cappuzzo F. Landi L, et al. Among authors: giannarelli d, d andrea mr. Future Oncol. 2022 Dec;18(40):4457-4464. doi: 10.2217/fon-2022-0913. Epub 2023 Mar 22. Future Oncol. 2022. PMID: 36946237
Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters.
Rescigno M, Agrati C, Salvarani C, Giannarelli D, Costantini M, Mantovani A, Massafra R, Zinzani PL, Morrone A, Notari S, Matusali G, Pinter GL, Uccelli A, Ciliberto G, Baldanti F, Locatelli F, Silvestris N, Sinno V, Turola E, Lupo-Stanghellini MT, Apolone G; VAX4FRAIL study Group. Rescigno M, et al. Among authors: giannarelli d. Front Immunol. 2023 Jan 27;14:1104124. doi: 10.3389/fimmu.2023.1104124. eCollection 2023. Front Immunol. 2023. PMID: 36776853 Free PMC article.
Dynamic changes in peripheral lymphocytes and antibody response following a third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in cancer patients.
Ruggeri EM, Nelli F, Giannarelli D, Fabbri A, Giron Berrios JR, Virtuoso A, Marrucci E, Mazzotta M, Schirripa M, Signorelli C, Chilelli MG, Primi F, Fiore C, Panichi V, Topini G, Silvestri MA. Ruggeri EM, et al. Among authors: giannarelli d. Sci Rep. 2022 Dec 19;12(1):21908. doi: 10.1038/s41598-022-25558-8. Sci Rep. 2022. PMID: 36535985 Free PMC article.
Treatment Sequencing and Outcome of Chronic Lymphocytic Leukemia Patients Treated at Fondazione Policlinico Universitario Agostino Gemelli IRCCS: A Thirty-Year Single-Center Experience.
Innocenti I, Fresa A, Tomasso A, Tarnani M, De Padua L, Benintende G, Pasquale R, Galli E, Morelli F, Giannarelli D, Autore F, Laurenti L. Innocenti I, et al. Among authors: giannarelli d. Cancers (Basel). 2023 Nov 26;15(23):5592. doi: 10.3390/cancers15235592. Cancers (Basel). 2023. PMID: 38067296 Free PMC article.
Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival?
Sassu CM, Marchetti C, Russo G, Minucci A, Boccia SM, Benato A, Nero C, Piermattei A, Mattogno PP, Giannarelli D, Ferrandina G, Olivi A, Fagotti A, Scambia G. Sassu CM, et al. Among authors: giannarelli d. Int J Gynecol Cancer. 2024 Jan 5;34(1):88-98. doi: 10.1136/ijgc-2023-004980. Int J Gynecol Cancer. 2024. PMID: 38805344
Clinical characteristics and survival outcome of early-stage, high-grade, serous tubo-ovarian carcinoma according to BRCA mutational status.
Marchetti C, Ataseven B, Perrone AM, Cassani C, Fruscio R, Sassu CM, Apostol AI, Harter P, De Iaco P, Camnasio CA, Moubarak M, Giannarelli D, Scambia G, Fagotti A. Marchetti C, et al. Among authors: giannarelli d. Gynecol Oncol. 2024 May 23;187:170-177. doi: 10.1016/j.ygyno.2024.05.008. Online ahead of print. Gynecol Oncol. 2024. PMID: 38788514
Feasibility and operative outcomes of surgery in the liver area in advanced ovarian cancer.
Rosati A, De Rose AM, Gallotta V, Giannarelli D, Ghirardi V, Pavone M, De Palma A, Conte C, Marchetti C, Gallucci V, Ardito F, Giuliante F, Querleu D, Scambia G, Fagotti A. Rosati A, et al. Among authors: giannarelli d. Gynecol Oncol. 2024 May 14;187:98-104. doi: 10.1016/j.ygyno.2024.04.019. Online ahead of print. Gynecol Oncol. 2024. PMID: 38749171 Free article.
Radiomics analysis of ultrasound images to discriminate between benign and malignant adnexal masses with solid ultrasound morphology.
Moro F, Vagni M, Tran HE, Bernardini F, Mascilini F, Ciccarone F, Nero C, Giannarelli D, Boldrini L, Fagotti A, Scambia G, Valentin L, Testa AC. Moro F, et al. Among authors: giannarelli d. Ultrasound Obstet Gynecol. 2024 May 15. doi: 10.1002/uog.27680. Online ahead of print. Ultrasound Obstet Gynecol. 2024. PMID: 38748935
Comparison between indolent systemic mastocytosis and clonal mast cell disease not meeting WHO diagnostic criteria: A nationwide multicenter retrospective analysis.
Sciumè M, Serpenti F, Zanotti R, Bonadonna P, Tanasi I, Crosera L, Elena C, Mannelli F, Crupi F, Papayannidis C, Sartor C, Soverini S, Rondoni M, Eller-Vainicher C, Pravettoni V, Rivolta F, Alberti Violetti S, Croci GA, Migliorini AC, Bolli N, Giannarelli D, Grifoni FI. Sciumè M, et al. Among authors: giannarelli d. Hematol Oncol. 2024 May;42(3):e3277. doi: 10.1002/hon.3277. Hematol Oncol. 2024. PMID: 38682493 No abstract available.
584 results